BRUKER CORP BRKR

Latest FY: 2025 Healthcare Medical Devices
Market Price $57.70
Market Cap $8.82B
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑2.1% YoY
$3.44B
3-Yr CAGR: 10.7%
Net Income ↓-107.6% YoY
-$8.60M
Net Margin: -0.3%
Free Cash Flow ↓-68.2% YoY
$43.30M
FCF Yield: 0.49%
EPS (Diluted) ↓-119.7% YoY
$-0.15
Basic: $-0.15
Return on Equity Efficiency
-0.4%
ROA: -0.4%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (BRKR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,611.3M $742.5M $153.6M $0.95 $130.8M $93.7M
FY 2017 $1,765.9M +9.6% $813.0M $78.6M -48.8% $0.49 -48.4% $154.4M $110.7M +18.1%
FY 2018 $1,895.6M +7.3% $900.0M $179.7M +128.6% $1.14 +132.7% $239.7M $190.5M +72.1%
FY 2019 $2,072.6M +9.3% $995.3M $197.2M +9.7% $1.26 +10.5% $213.4M $140.4M -26.3%
FY 2020 $1,987.5M -4.1% $939.8M $157.8M -20.0% $1.02 -19.0% $332.2M $235.0M +67.4%
FY 2021 $2,417.9M +21.7% $1,209.6M $277.1M +75.6% $1.81 +77.5% $282.4M $190.4M -19.0%
FY 2022 $2,530.7M +4.7% $1,305.7M $296.6M +7.0% $1.99 +9.9% $274.4M $145.2M -23.7%
FY 2023 $2,964.5M +17.1% $1,513.3M $427.2M +44.0% $2.90 +45.7% $350.1M $243.2M +67.5%
FY 2024 $3,366.4M +13.6% $1,649.5M $113.1M -73.5% $0.76 -73.8% $251.3M $136.0M -44.1%
FY 2025 $3,436.5M +2.1% $1,577.7M $-8.6M -107.6% $-0.15 -119.7% $134.1M $43.3M -68.2%
$

Valuation

Market Price $57.70
Market Cap $8.82B
Enterprise Value $10.37B
P/E Ratio N/A
P/B Ratio 3.58
FCF Yield 0.49%
Dividend Yield -0.26%
Shares Outstanding 152,225,600
%

Profitability & Margins

Gross Margin 45.91%
Operating Margin 1.98%
Net Margin -0.25%
Return on Equity (ROE) -0.35%
Return on Assets (ROA) -0.39%
Asset Turnover 1.55x
Revenue 3-Yr CAGR 10.74%
🛡️

Financial Health & Liquidity

Current Ratio 1.73
Cash Ratio 0.23
Debt / Equity 0.754
Debt / Assets 0.837
Cash & Equivalents $298.80M
Total Debt $1.85B
Book Value / Share $16.14
💧

Cash Flow Efficiency

Operating Cash Flow $134.10M
Capital Expenditures (CapEx) $90.80M
Free Cash Flow $43.30M
OCF / Revenue 3.90%
FCF / Revenue 1.26%
FCF 3-Yr CAGR -33.19%
🏷️

Per Share Metrics

EPS (Diluted) $-0.15
EPS (Basic) $-0.15
Dividends / Share $-0.15
Book Value / Share $16.14
EPS YoY Growth -119.74%
🏛️

Balance Sheet (FY 2025)

Total Assets $2.21B
Total Liabilities $1.28B
Stockholders' Equity $2.46B
Current Assets $2.21B
Current Liabilities $1.28B